Hannah Elvington

Hannah Elvington is a Senior Manager in Global Regulatory Affairs at Compass Pathways, where they lead regulatory strategies for innovative drug development. With over five years of experience in both small and large biotech firms, they have worked on managing INDs, BLAs, and NDAs, and have gained expertise in FDA interactions. Previously, Hannah served as a Manager in US Regulatory Affairs at Biogen and as a Global Regulatory Affairs Specialist at TG Therapeutics, contributing significantly to regulatory assessments and strategies. They hold a Bachelor of Science in Public Health from Meredith College, where they also engaged in undergraduate research focused on environmental drivers of dengue emergence.